W STRATEGIES, LLC

Lobbying for GILEAD SCIENCES, INC. · American biotechnology company that researches, develops and commercializes drugs.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · $60,000.00 income · posted Jan 20, 2026

Bills named in this filing 1

Lobbying activity 2

Medicare/Medicaid

Implementation H.R.5376 - Inflation Reduction Act of 2022. Public Law 119-21: One Big Beautiful Bill Act.

Health Issues

Education about access to HIV medicines. Education about the 340(b) program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.